Surrozen’s Wnt mimetic antibody improves lung function in mice with pulmonary fibrosis
A Wnt/β-catenin pathway agonist under development by Surrozen appears to be effective against idiopathic pulmonary fibrosis (IPF) in mouse models, according to new data.